Pharmacology Exam 3 Study Guide Quiz

153 Questions | By Nhv031000 | Updated: Mar 22, 2022 | Attempts: 153

Questions

Settings

Pharmacology Exam 3 Study Guide Quiz - Quiz

There are different ways that one can review the materials they have learnt in class and this can either be through study groups, checking past tests or looking for practice questions. The study guide quiz below is the third in a series of tests designed to adequately prepare you for the pharmacology exam. Why don’t you give it a shot and see just how high you will score?

Questions and Answers

1.

_____________ is the most important fuel for the brain.
- A.
  
  Fructose
- B.
  
  Sucrose
- C.
  
  Galactose
- D.
  
  Glucose
2.

Brain glucose uptake occurs at different rates during absorptive and post-absorptive periods and is not altered in type 2 diabetes.
- A.
  
  True
- B.
  
  False
3.

What type of cells releases insulin?
- A.
  
  Pancreatic β cells
- B.
  
  Pancreatic α cells
- C.
  
  Follicular cells
- D.
  
  Pancreatic δ cells
4.

Which of the following are specific-defined gene mutations of diabetes Mellitus?
- A.
  
  Type 1 diabetes
- B.
  
  Type 2 diabetes
- C.
  
  MODY
5.

Hyperinsulinemia is a condition in which normal amounts of insulin are ineffective in lowering plasma glucose concentrations.
- A.
  
  True
- B.
  
  False
6.

Insulin can bind to IGF receptors with high affinity.
- A.
  
  True
- B.
  
  False
7.

Glucose is taken up by pancreatic β cells via _____________.
- A.
  
  GLUT1
- B.
  
  GLUT2
- C.
  
  GLUT3
- D.
  
  GLUT4
8.

Glucose is ___________ by glucokinase.
- A.
  
  Dephosphorylated
- B.
  
  Phosphorylated
- C.
  
  Acetylated
- D.
  
  Hydrolyzed
9.

What is the 1st phase in biphasic insulin secretion?
- A.
  
  Fusion
- B.
  
  Translocation
- C.
  
  Diffusion
- D.
  
  Transfusion
10.

What is the 2nd phase in biphasic insulin secretion?
- A.
  
  Transport
- B.
  
  Translocation
- C.
  
  Transduce
- D.
  
  Transfuse
11.

What type of cells releases glucagon?
- A.
  
  Pancreatic F cells
- B.
  
  Pancreatic β cells
- C.
  
  Pancreatic δ cells
- D.
  
  Pancreatic α cells
12.

Insulin secretion is biphasic.
- A.
  
  True
- B.
  
  False
13.

Glucagon increases gluconeogenesis and glycogenolysis.
- A.
  
  True
- B.
  
  False
14.

Glucagon is an antagonist for G-protein coupled receptor (GPCR) that signals via stimulatory G-protein (Gs).
- A.
  
  True
- B.
  
  False
15.

Which of the following are "metabolic effects"?
- A.
  
  Glucose uptake
- B.
  
  Increased Gluconeogenesis
- C.
  
  Glycogen synthesis
- D.
  
  Lipogenesis
16.

_____________ signaling events involved in "metabolic" signaling by insulin.
- A.
  
  PI-1 Kinase
- B.
  
  PI-2 Kinase
- C.
  
  PI-3 Kinase
- D.
  
  PI-4 Kinase
17.

Dysregulation of insulin signaling pathways is one of the hallmarks of Type I diabetes.
- A.
  
  True
- B.
  
  False
18.

Hepatic glucose production is altered in Type 2 diabetes.
- A.
  
  True
- B.
  
  False
19.

If the liver is insulin-resistant, it will continue to produce glucose leading to marked hyperglycemia.
- A.
  
  True
- B.
  
  False
20.

Hypoglycemia is a potent inhibitor of hepatic glucose output (HGO).
- A.
  
  True
- B.
  
  False
21.

_______________ occurs when the body cannot use glucose as a fuel source because the body has no insulin or not enough insulin, and fat is used instead.
- A.
  
  Diabetic ketoacidosis
- B.
  
  Nonketotic coma
- C.
  
  Diabetic retinopathy
- D.
  
  Hypertension
22.

The following can greatly improve outcomes for diabetic patients:
- A.
  
  Early diagnosis
- B.
  
  Careful glucose monitoring
- C.
  
  Control
- D.
  
  Prevention
23.

Glycosylated hemoglobin is a critical biomarker for glucose control.
- A.
  
  True
- B.
  
  False
24.

Insulin resistance/Metabolic syndrome is constellation of symptoms most often associated with obesity.
- A.
  
  True
- B.
  
  False
25.

One of the glycemic goals is to maintain fasting blood glucose between ____________.
- A.
  
  70-130 mg/dL
- B.
  
  10-60 mg/dL
- C.
  
  150-220 mg/dL
- D.
  
  240-300 mg/dL